Consensus ESG Ratings
Member Sign In
ESG News For GlaxoSmithKline Pharmaceuticals Ltd.
These sites contributed news to this page:
-
ViiV Healthcare announces £3 million global fund to research the impact of COVID-19 on the HIV community and fill gaps in prevention, treatment and care during the pandemic
ViiV HC announces £3 million global fund to research the impact of COVID-19 on the HIV community and fill gaps in prevention, treatment, and care -
Moving Mountains for Multiple Myeloma® to Hike Through Lava Fields and Volcanoes in Iceland
A group of 14 individuals will embark on this challenge to raise awareness for multiple myeloma -
One Drop Foundation and Global Wholesaler METRO to Join Forces – to Provide Safe Water Access and Sanitation for More Than 250,000 People in India
Fundraising efforts begin today in partnership across 22 countries with 22 global suppliers and will be three-year annual effort -
Inclusion Initiative Companies Spend More than $240 Million in 2017 on Minority and Women Owned Law Firms
Inclusion Initiative Companies Spend More than $240 Million in 2017 on Minority and Women Owned Law Firms -
PPG Appoints Malesia Dunn, Executive Director, PPG Foundation and Corporate Global Social Responsibility
PPG (NYSE:PPG) today announced the appointment of Malesia Dunn as executive director, PPG Foundation and corporate global social responsibility. In this role, Dunn will report to Bryan Iams, PPG vice president, corporate and government affairs and succeed Sue Sloan, current executive director, who will retire, effective Aug. 1, 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180717005665/en/ PPG app